Alzheimer's & Cognition
Conference Coverage
Positive functional results reported for aducanumab in a pooled, post hoc analysis
SAN DIEGO – The results might give patients “an extra year or 2” of independence, said one clinical investigator in an aducanumab trial.
Conference Coverage
Intensive BP control reduced dementia but increased brain atrophy and hurt cognition
SAN DIEGO – The small but significant ill effects worried some researchers at the Clinical Trials on Alzheimer’s Disease...
From the Journals
‘Brain enhancement’ supplements sold online may illegally contain piracetam
So-called cognitive enhancement supplements sold online may contain high doses of the nootropic drug piracetam.
From the Journals
Alzheimer’s disease subtypes follow neuropathologic patterns seen in the nucleus basalis of Meynert
Feature
Seaweed floats to the top of Alzheimer’s news
Chinese regulators have approved sodium oligomannate, an extract of brown algae, as a treatment for mild to moderate Alzheimer’s. But questions...
Literature Review
Survey asks adults: How likely are you to develop dementia?
Adults are worried about dementia and will do anything to prevent it. Except talk to their doctor.
Conference Coverage
Blood test might rival PET scan for detecting brain amyloidosis
ST. LOUIS – A blood test that measures the plasma ratio of amyloid-beta 42 peptide to amyloid-beta peptide 40 can accurately screen cognitively...
Feature
Dr. Paul Aisen Q&A: Aducanumab for Alzheimer’s
A leading Alzheimer’s researcher, Dr. Aisen answers some questions about the resurrection of aducanumab as a potential therapy for Alzheimer’s...
Feature
Biogen plans to submit application to FDA for Alzheimer’s drug aducanumab
The company’s hopes lie with a secondary analysis of high-dose patients from two failed trials.
From the Journals
Soccer pros may face increased risk of death from neurodegenerative disease
Mortality associated with neurodegenerative disease was higher, and mortality associated with other causes lower, among former pro soccer players...
Conference Coverage
Certain diabetes drugs may thwart dementia
COPENHAGEN – Intriguing findings from a Danish national registry study.